• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center
eNews, DF/HCC's online quarterly newsletter, highlights the groundbreaking research, news, and events taking place within DF/HCC, and showcases the services and tools DF/HCC offers to facilitate collaboration and discovery in the Harvard community.

Welcome to Dana-Farber/Harvard Cancer Center

Dana-Farber/Harvard Cancer Center (DF/HCC) is the largest comprehensive cancer center in the world, bringing together the cancer research efforts of our seven member institutions: Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Harvard School of Public Health, and Massachusetts General Hospital.

Funded by a grant from the National Cancer Institute, we have joined these seven renowned Harvard-affiliated medical centers into one collective force dedicated to the fight against cancer. Based in Boston, DF/HCC consists of more than 1,000 researchers with a singular goal -- to find new and innovative ways to combat cancer.

Latest Cancer News

    Four DF/HCC Members Elected to the Institute of Medicine

    October 23, 2014 The Institute of Medicine (IOM) recently announced 70 new members, four of which are DF/HCC researchers. Membership to the IOM is among the highest... | [more]

    DF/HCC CURE Program Celebrates Thirteen Years of Success

    October 2014 | eNewsThis year, 32 Scholars participated in the NCI Continuing Umbrella of Research Experiences (CURE) program, a hands-on research training experience for... | [more]

    Using Mathematics to Predict the Best Dose

    October 2014 | eNews Franziska Michor, PhD (DFCI), applies mathematical modeling to try to predict how cancers accumulate mutations and other changes and how these... | [more]